> top > docs > PMC:3342329 > spans > 25171-26254 > annotations

PMC:3342329 / 25171-26254 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T8994 1070-1074 Protein denotes CCR5
T8993 1012-1018 Protein denotes IL-1Ra
T8992 1000-1008 Positive_regulation denotes increase
T8991 861-867 Protein denotes IL-1Ra
T8990 848-857 Positive_regulation denotes increased
T8989 829-837 Negative_regulation denotes knockout
T8988 823-828 Protein denotes IL-1α
T8987 812-819 Negative_regulation denotes reduced
T8986 654-660 Protein denotes IL-1Ra
T8985 267-273 Protein denotes IL-1Ra
T8984 258-266 Positive_regulation denotes elevated
T8983 238-247 Negative_regulation denotes decreased
T8982 211-221 Gene_expression denotes production
T8981 206-210 Protein denotes IL-6
T8980 195-205 Negative_regulation denotes decreasing
T8903 1070-1074 Protein denotes CCR5
T8902 1012-1018 Protein denotes IL-1Ra
T8901 861-867 Protein denotes IL-1Ra
T8900 823-828 Protein denotes IL-1α
T8899 654-660 Protein denotes IL-1Ra
T8898 267-273 Protein denotes IL-1Ra
T8897 206-210 Protein denotes IL-6
R5911 T8981 T8982 themeOf IL-6,production
R5912 T8982 T8980 themeOf production,decreasing
R5913 T8985 T8984 themeOf IL-1Ra,elevated
R5914 T8988 T8989 themeOf IL-1α,knockout
R5915 T8989 T8987 themeOf knockout,reduced
R5916 T8991 T8990 themeOf IL-1Ra,increased
R5917 T8993 T8992 themeOf IL-1Ra,increase

testone

Id Subject Object Predicate Lexical cue
T8847 1000-1008 Positive_regulation denotes increase
T8846 972-980 Negative_regulation denotes decrease
T8845 848-857 Positive_regulation denotes increased
T8844 829-837 Negative_regulation denotes knockout
T8843 812-819 Negative_regulation denotes reduced
T8842 258-266 Positive_regulation denotes elevated
T8841 238-247 Negative_regulation denotes decreased
T8840 211-221 Gene_expression denotes production
T8839 195-205 Negative_regulation denotes decreasing
T8810 1070-1074 Protein denotes CCR5
T8809 1012-1018 Protein denotes IL-1Ra
T8808 861-867 Protein denotes IL-1Ra
T8807 823-828 Protein denotes IL-1α
T8806 654-660 Protein denotes IL-1Ra
T8805 267-273 Protein denotes IL-1Ra
T8804 206-210 Protein denotes IL-6
R5883 T8804 T8840 themeOf IL-6,production
R5884 T8805 T8842 themeOf IL-1Ra,elevated
R5885 T8807 T8844 themeOf IL-1α,knockout
R5886 T8809 T8847 themeOf IL-1Ra,increase
R5894 T8840 T8839 themeOf production,decreasing
R5895 T8844 T8843 themeOf knockout,reduced

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T11164 1012-1018 Protein denotes IL-1Ra
T11163 861-867 Protein denotes IL-1Ra
T11162 823-828 Protein denotes IL-1α
T11161 654-660 Protein denotes IL-1Ra
T11160 267-273 Protein denotes IL-1Ra
T11159 206-210 Protein denotes IL-6
T11195 1000-1008 Positive_regulation denotes increase
T11194 848-857 Positive_regulation denotes increased
T11193 829-837 Negative_regulation denotes knockout
T11192 812-819 Negative_regulation denotes reduced
T11191 258-266 Positive_regulation denotes elevated
T11190 211-221 Gene_expression denotes production
T11189 195-205 Negative_regulation denotes decreasing
T11165 1070-1074 Protein denotes CCR5
R7410 T11159 T11190 themeOf IL-6,production
R7411 T11160 T11191 themeOf IL-1Ra,elevated
R7413 T11162 T11192 themeOf IL-1α,reduced
R7414 T11162 T11193 themeOf IL-1α,knockout
R7415 T11163 T11194 themeOf IL-1Ra,increased
R7416 T11164 T11195 themeOf IL-1Ra,increase
R7426 T11190 T11189 themeOf production,decreasing

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T10837 1070-1074 Protein denotes CCR5
T10836 1012-1018 Protein denotes IL-1Ra
T10835 861-867 Protein denotes IL-1Ra
T10834 823-828 Protein denotes IL-1α
T10833 654-660 Protein denotes IL-1Ra
T10832 267-273 Protein denotes IL-1Ra
T10831 206-210 Protein denotes IL-6
T10869 1000-1008 Positive_regulation denotes increase
T10868 812-819 Negative_regulation denotes reduced
T10867 829-837 Negative_regulation denotes knockout
T10866 258-266 Positive_regulation denotes elevated
T10865 211-221 Gene_expression denotes production
T10864 195-205 Negative_regulation denotes decreasing
R7321 T10831 T10865 themeOf IL-6,production
R7322 T10832 T10866 themeOf IL-1Ra,elevated
R7323 T10834 T10868 themeOf IL-1α,reduced
R7324 T10834 T10867 themeOf IL-1α,knockout
R7325 T10836 T10869 themeOf IL-1Ra,increase
R7333 T10865 T10864 themeOf production,decreasing

2_test

Id Subject Object Predicate Lexical cue
22567084-20235165-91707054 90-92 20235165 denotes 49
22567084-16328384-91707055 223-225 16328384 denotes 50
22567084-20428758-91707056 509-511 20428758 denotes 51
22567084-20332438-91707057 756-758 20332438 denotes 25
22567084-19342666-91707058 938-940 19342666 denotes 52

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T10645 1078-1082 NN denotes mice
T10644 1070-1077 NN denotes CCR5−/−
T10643 1067-1069 IN denotes of
T10642 1056-1066 NN denotes inhibition
T10641 1049-1055 NN denotes growth
T10640 1043-1048 NN denotes tumor
T10639 1040-1042 IN denotes in
T10638 1028-1039 JJ denotes significant
T10637 1025-1027 VB denotes be
T10636 1019-1024 MD denotes could
T10635 1012-1018 NN denotes IL-1Ra
T10634 1009-1011 IN denotes of
T10633 1000-1008 NN denotes increase
T10632 995-999 RB denotes thus
T10631 991-994 CC denotes and
T10630 989-990 -COMMA- denotes ,
T10629 984-989 NN denotes NF-κB
T10628 981-983 IN denotes of
T10627 972-980 NN denotes decrease
T10626 968-971 DT denotes the
T10625 963-967 IN denotes that
T10624 954-962 VB denotes indicate
T10623 949-953 NN denotes data
T10622 943-948 DT denotes These
T10621 940-941 -RRB- denotes ]
T10620 938-940 CD denotes 52
T10619 937-938 -LRB- denotes [
T10618 928-936 NN denotes immunity
T10617 917-927 JJ denotes anti-tumor
T10616 913-916 CC denotes and
T10615 907-912 NN denotes cells
T10614 904-906 NN denotes NK
T10613 901-903 IN denotes of
T10612 890-900 NN denotes maturation
T10611 878-889 JJ denotes concomitant
T10610 873-877 IN denotes with
T10609 868-872 NN denotes mice
T10608 861-867 NN denotes IL-1Ra
T10607 858-860 IN denotes in
T10606 848-857 VB denotes increased
T10605 844-847 CC denotes but
T10604 842-843 -COMMA- denotes ,
T10603 838-842 NN denotes mice
T10602 829-837 NN denotes knockout
T10601 823-828 NN denotes IL-1α
T10600 820-822 IN denotes in
T10599 812-819 VB denotes reduced
T10598 808-811 VB denotes was
T10597 798-807 NN denotes incidence
T10596 792-797 NN denotes tumor
T10595 765-791 JJ denotes 3-methylcholatrene-induced
T10594 761-764 DT denotes The
T10593 758-759 -RRB- denotes ]
T10592 756-758 CD denotes 25
T10591 755-756 -LRB- denotes [
T10590 749-754 NN denotes tumor
T10589 746-748 IN denotes in
T10588 740-745 NN denotes cells
T10587 729-739 NN denotes suppressor
T10586 721-728 JJ denotes myeloid
T10585 718-720 IN denotes of
T10584 711-717 NN denotes number
T10583 707-710 DT denotes the
T10582 696-706 VB denotes increasing
T10581 693-695 IN denotes by
T10580 686-692 NN denotes growth
T10579 680-685 NN denotes tumor
T10578 671-679 NN denotes melanoma
T10577 661-670 VB denotes inhibited
T10576 654-660 NN denotes IL-1Ra
T10575 649-653 IN denotes that
T10574 638-648 JJ denotes noteworthy
T10573 633-637 RB denotes also
T10572 630-632 VB denotes is
T10571 627-629 PRP denotes It
T10570 620-625 NN denotes cells
T10569 613-619 JJ denotes immune
T10568 610-612 IN denotes of
T10567 599-609 NN denotes activities
T10566 588-598 JJ denotes anti-tumor
T10565 579-587 VB denotes mediated
T10564 570-578 NN denotes cytokine
T10563 566-569 DT denotes the
T10562 563-565 IN denotes in
T10561 554-562 VB denotes involved
T10560 551-553 VB denotes be
T10559 545-550 MD denotes could
T10558 539-544 NN denotes NF-κB
T10557 534-538 IN denotes that
T10556 525-533 VB denotes indicate
T10555 520-524 NN denotes data
T10554 514-519 DT denotes These
T10553 511-512 -RRB- denotes ]
T10552 509-511 CD denotes 51
T10551 508-509 -LRB- denotes [
T10550 502-507 NN denotes tumor
T10549 497-501 JJ denotes oral
T10548 494-496 IN denotes in
T10547 481-493 NN denotes infiltration
T10546 476-480 NN denotes cell
T10545 469-475 JJ denotes immune
T10544 465-468 CC denotes and
T10543 459-464 NN denotes NF-κB
T10542 449-458 VB denotes increased
T10541 447-448 -COMMA- denotes ,
T10540 439-447 NN denotes cytokine
T10539 429-438 VB denotes promoting
T10538 422-428 NN denotes growth
T10537 416-421 NN denotes tumor
T10536 414-415 DT denotes a
T10535 412-413 -COMMA- denotes ,
T10534 407-412 NN denotes IL-23
T10533 405-406 -COMMA- denotes ,
T10532 397-405 NN denotes contrast
T10531 394-396 IN denotes In
T10530 382-392 NN denotes inhibition
T10529 375-381 NN denotes growth
T10528 369-374 NN denotes tumor
T10527 366-368 IN denotes in
T10526 356-365 VB denotes resulting
T10525 354-355 -COMMA- denotes ,
T10524 349-354 NN denotes tumor
T10523 344-348 IN denotes into
T10522 332-343 NN denotes lymphocytes
T10521 322-331 JJ denotes cytotoxic
T10520 319-321 IN denotes of
T10519 306-318 NN denotes infiltration
T10518 302-305 DT denotes the
T10517 299-301 IN denotes in
T10516 288-298 VB denotes associated
T10515 285-287 VB denotes be
T10514 280-284 RB denotes also
T10513 274-279 MD denotes could
T10512 267-273 NN denotes IL-1Ra
T10511 258-266 JJ denotes elevated
T10510 254-257 CC denotes and
T10509 248-253 NN denotes NF-κB
T10508 238-247 VB denotes decreased
T10507 234-237 DT denotes the
T10506 232-233 -COMMA- denotes ,
T10505 228-232 RB denotes Thus
T10504 225-226 -RRB- denotes ]
T10503 223-225 CD denotes 50
T10502 222-223 -LRB- denotes [
T10501 211-221 NN denotes production
T10500 206-210 NN denotes IL-6
T10499 195-205 VB denotes decreasing
T10498 192-194 IN denotes by
T10497 183-191 NN denotes activity
T10496 172-182 JJ denotes anti-tumor
T10495 162-171 VB denotes increased
T10494 157-161 RB denotes thus
T10493 153-156 CC denotes and
T10492 151-152 -COMMA- denotes ,
T10491 142-151 NN denotes depletion
T10490 137-141 NN denotes cell
T10489 134-136 NN denotes NK
T10488 124-133 VB denotes prevented
T10487 115-123 NN denotes activity
T10486 109-114 NN denotes NF-κB
T10485 106-108 IN denotes of
T10484 95-105 NN denotes Inhibition
T10483 92-93 -RRB- denotes ]
T10482 90-92 CD denotes 49
T10481 89-90 -LRB- denotes [
T10480 76-88 NN denotes pathogenesis
T10479 72-75 CC denotes and
T10478 66-71 NN denotes cells
T10477 63-65 NN denotes NK
T10476 60-62 IN denotes of
T10475 47-59 NN denotes localization
T10474 35-46 JJ denotes subcellular
T10473 26-34 VB denotes modulate
T10472 20-25 MD denotes could
T10471 14-19 NN denotes NF-κB
T10470 11-13 IN denotes of
T10469 0-10 NN denotes Activation
R7030 T10469 T10470 arg1Of Activation,of
R7031 T10469 T10472 arg1Of Activation,could
R7032 T10469 T10473 arg1Of Activation,modulate
R7033 T10471 T10470 arg2Of NF-κB,of
R7034 T10473 T10472 arg2Of modulate,could
R7035 T10475 T10474 arg1Of localization,subcellular
R7036 T10475 T10476 arg1Of localization,of
R7037 T10475 T10479 arg1Of localization,and
R7038 T10478 T10476 arg2Of cells,of
R7039 T10478 T10477 arg1Of cells,NK
R7040 T10479 T10473 arg2Of and,modulate
R7041 T10480 T10479 arg2Of pathogenesis,and
R7042 T10480 T10481 arg1Of pathogenesis,[
R7043 T10482 T10481 arg2Of 49,[
R7044 T10483 T10481 arg3Of ],[
R7045 T10484 T10485 arg1Of Inhibition,of
R7046 T10484 T10488 arg1Of Inhibition,prevented
R7047 T10484 T10495 arg1Of Inhibition,increased
R7048 T10484 T10499 arg1Of Inhibition,decreasing
R7049 T10487 T10485 arg2Of activity,of
R7050 T10487 T10486 arg1Of activity,NF-κB
R7051 T10488 T10493 arg1Of prevented,and
R7052 T10491 T10488 arg2Of depletion,prevented
R7053 T10491 T10489 arg1Of depletion,NK
R7054 T10491 T10490 arg1Of depletion,cell
R7055 T10493 T10492 arg1Of and,","
R7056 T10495 T10493 arg2Of increased,and
R7057 T10495 T10494 arg1Of increased,thus
R7058 T10495 T10498 arg1Of increased,by
R7059 T10497 T10495 arg2Of activity,increased
R7060 T10497 T10496 arg1Of activity,anti-tumor
R7061 T10499 T10498 arg2Of decreasing,by
R7062 T10499 T10502 arg1Of decreasing,[
R7063 T10501 T10499 arg2Of production,decreasing
R7064 T10501 T10500 arg1Of production,IL-6
R7065 T10503 T10502 arg2Of 50,[
R7066 T10504 T10502 arg3Of ],[
R7067 T10509 T10508 arg2Of NF-κB,decreased
R7068 T10509 T10510 arg1Of NF-κB,and
R7069 T10510 T10507 arg1Of and,the
R7070 T10510 T10513 arg1Of and,could
R7071 T10510 T10515 arg1Of and,be
R7072 T10510 T10516 arg2Of and,associated
R7073 T10512 T10510 arg2Of IL-1Ra,and
R7074 T10512 T10511 arg1Of IL-1Ra,elevated
R7075 T10516 T10505 arg1Of associated,Thus
R7076 T10516 T10506 arg1Of associated,","
R7077 T10516 T10513 arg2Of associated,could
R7078 T10516 T10514 arg1Of associated,also
R7079 T10516 T10515 arg2Of associated,be
R7080 T10516 T10517 arg1Of associated,in
R7081 T10516 T10523 arg1Of associated,into
R7082 T10516 T10525 arg1Of associated,","
R7083 T10516 T10526 modOf associated,resulting
R7084 T10519 T10517 arg2Of infiltration,in
R7085 T10519 T10518 arg1Of infiltration,the
R7086 T10519 T10520 arg1Of infiltration,of
R7087 T10522 T10520 arg2Of lymphocytes,of
R7088 T10522 T10521 arg1Of lymphocytes,cytotoxic
R7089 T10524 T10523 arg2Of tumor,into
R7090 T10526 T10527 arg1Of resulting,in
R7091 T10530 T10527 arg2Of inhibition,in
R7092 T10530 T10528 arg1Of inhibition,tumor
R7093 T10530 T10529 arg1Of inhibition,growth
R7094 T10532 T10531 arg2Of contrast,In
R7095 T10534 T10535 arg1Of IL-23,","
R7096 T10534 T10542 arg1Of IL-23,increased
R7097 T10540 T10535 arg2Of cytokine,","
R7098 T10540 T10536 arg1Of cytokine,a
R7099 T10540 T10537 arg1Of cytokine,tumor
R7100 T10540 T10538 arg1Of cytokine,growth
R7101 T10540 T10539 arg1Of cytokine,promoting
R7102 T10542 T10531 arg1Of increased,In
R7103 T10542 T10533 arg1Of increased,","
R7104 T10542 T10541 arg1Of increased,","
R7105 T10542 T10551 arg1Of increased,[
R7106 T10543 T10544 arg1Of NF-κB,and
R7107 T10544 T10542 arg2Of and,increased
R7108 T10544 T10548 arg1Of and,in
R7109 T10547 T10544 arg2Of infiltration,and
R7110 T10547 T10545 arg1Of infiltration,immune
R7111 T10547 T10546 arg1Of infiltration,cell
R7112 T10550 T10548 arg2Of tumor,in
R7113 T10550 T10549 arg1Of tumor,oral
R7114 T10552 T10551 arg2Of 51,[
R7115 T10553 T10551 arg3Of ],[
R7116 T10555 T10554 arg1Of data,These
R7117 T10555 T10556 arg1Of data,indicate
R7118 T10558 T10559 arg1Of NF-κB,could
R7119 T10558 T10560 arg1Of NF-κB,be
R7120 T10558 T10561 arg2Of NF-κB,involved
R7121 T10561 T10556 arg2Of involved,indicate
R7122 T10561 T10557 arg1Of involved,that
R7123 T10561 T10559 arg2Of involved,could
R7124 T10561 T10560 arg2Of involved,be
R7125 T10561 T10562 arg1Of involved,in
R7126 T10564 T10562 arg2Of cytokine,in
R7127 T10564 T10563 arg1Of cytokine,the
R7128 T10567 T10562 arg3Of activities,in
R7129 T10567 T10565 arg2Of activities,mediated
R7130 T10567 T10566 arg1Of activities,anti-tumor
R7131 T10567 T10568 arg1Of activities,of
R7132 T10570 T10568 arg2Of cells,of
R7133 T10570 T10569 arg1Of cells,immune
R7134 T10572 T10573 arg1Of is,also
R7135 T10574 T10572 arg2Of noteworthy,is
R7136 T10576 T10577 arg1Of IL-1Ra,inhibited
R7137 T10576 T10582 arg1Of IL-1Ra,increasing
R7138 T10577 T10571 arg1Of inhibited,It
R7139 T10577 T10572 arg1Of inhibited,is
R7140 T10577 T10574 arg1Of inhibited,noteworthy
R7141 T10577 T10575 arg1Of inhibited,that
R7142 T10577 T10581 arg1Of inhibited,by
R7143 T10580 T10577 arg2Of growth,inhibited
R7144 T10580 T10578 arg1Of growth,melanoma
R7145 T10580 T10579 arg1Of growth,tumor
R7146 T10582 T10581 arg2Of increasing,by
R7147 T10582 T10589 arg1Of increasing,in
R7148 T10584 T10582 arg2Of number,increasing
R7149 T10584 T10583 arg1Of number,the
R7150 T10584 T10585 arg1Of number,of
R7151 T10588 T10585 arg2Of cells,of
R7152 T10588 T10586 arg1Of cells,myeloid
R7153 T10588 T10587 arg1Of cells,suppressor
R7154 T10590 T10589 arg2Of tumor,in
R7155 T10590 T10591 arg1Of tumor,[
R7156 T10592 T10591 arg2Of 25,[
R7157 T10593 T10591 arg3Of ],[
R7158 T10597 T10594 arg1Of incidence,The
R7159 T10597 T10595 arg1Of incidence,3-methylcholatrene-induced
R7160 T10597 T10596 arg1Of incidence,tumor
R7161 T10597 T10598 arg1Of incidence,was
R7162 T10597 T10599 arg2Of incidence,reduced
R7163 T10597 T10606 arg1Of incidence,increased
R7164 T10599 T10598 arg2Of reduced,was
R7165 T10599 T10600 arg1Of reduced,in
R7166 T10599 T10605 arg1Of reduced,but
R7167 T10603 T10600 arg2Of mice,in
R7168 T10603 T10601 arg1Of mice,IL-1α
R7169 T10603 T10602 arg1Of mice,knockout
R7170 T10605 T10604 arg1Of but,","
R7171 T10606 T10605 arg2Of increased,but
R7172 T10606 T10607 arg1Of increased,in
R7173 T10606 T10610 arg1Of increased,with
R7174 T10609 T10607 arg2Of mice,in
R7175 T10609 T10608 arg1Of mice,IL-1Ra
R7176 T10612 T10611 arg1Of maturation,concomitant
R7177 T10612 T10613 arg1Of maturation,of
R7178 T10612 T10616 arg1Of maturation,and
R7179 T10615 T10613 arg2Of cells,of
R7180 T10615 T10614 arg1Of cells,NK
R7181 T10616 T10610 arg2Of and,with
R7182 T10618 T10616 arg2Of immunity,and
R7183 T10618 T10617 arg1Of immunity,anti-tumor
R7184 T10618 T10619 arg1Of immunity,[
R7185 T10620 T10619 arg2Of 52,[
R7186 T10621 T10619 arg3Of ],[
R7187 T10623 T10622 arg1Of data,These
R7188 T10623 T10624 arg1Of data,indicate
R7189 T10627 T10626 arg1Of decrease,the
R7190 T10627 T10628 arg1Of decrease,of
R7191 T10627 T10634 arg1Of decrease,of
R7192 T10627 T10636 arg1Of decrease,could
R7193 T10627 T10637 arg1Of decrease,be
R7194 T10627 T10638 arg1Of decrease,significant
R7195 T10629 T10631 arg1Of NF-κB,and
R7196 T10631 T10628 arg2Of and,of
R7197 T10631 T10630 arg1Of and,","
R7198 T10633 T10631 arg2Of increase,and
R7199 T10633 T10632 arg1Of increase,thus
R7200 T10635 T10634 arg2Of IL-1Ra,of
R7201 T10637 T10624 arg2Of be,indicate
R7202 T10637 T10625 arg1Of be,that
R7203 T10637 T10636 arg2Of be,could
R7204 T10638 T10637 arg2Of significant,be
R7205 T10638 T10639 arg1Of significant,in
R7206 T10642 T10639 arg2Of inhibition,in
R7207 T10642 T10640 arg1Of inhibition,tumor
R7208 T10642 T10641 arg1Of inhibition,growth
R7209 T10642 T10643 arg1Of inhibition,of
R7210 T10645 T10643 arg2Of mice,of
R7211 T10645 T10644 arg1Of mice,CCR5−/−

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T9212 1070-1074 Protein denotes CCR5
T9211 1012-1018 Protein denotes IL-1Ra
T9210 861-867 Protein denotes IL-1Ra
T9209 823-828 Protein denotes IL-1α
T9208 654-660 Protein denotes IL-1Ra
T9207 267-273 Protein denotes IL-1Ra
T9206 206-210 Protein denotes IL-6

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T10932 206-210 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T10917 1012-1018 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10916 861-867 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10915 654-660 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10914 267-273 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10897 1070-1074 http://www.uniprot.org/uniprot/P51681 denotes CCR5

GO-BP

Id Subject Object Predicate Lexical cue
T9288 206-221 http://purl.obolibrary.org/obo/GO_0032675 denotes IL-6 production
T9287 206-221 http://purl.obolibrary.org/obo/GO_0032635 denotes IL-6 production
T9286 76-88 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T9285 47-59 http://purl.obolibrary.org/obo/GO_0051179 denotes localization
T9238 1049-1066 http://purl.obolibrary.org/obo/GO_0045926 denotes growth inhibition
T9237 375-392 http://purl.obolibrary.org/obo/GO_0045926 denotes growth inhibition
T9233 1049-1055 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9232 686-692 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9231 422-428 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9230 375-381 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

GO-MF

Id Subject Object Predicate Lexical cue
T9334 407-412 http://purl.obolibrary.org/obo/GO_0045519 denotes IL-23
T9328 206-210 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6

GO-CC

Id Subject Object Predicate Lexical cue
T9308 907-912 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9307 740-745 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9306 620-625 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9305 66-71 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T9054 943-1083 Sentence denotes These data indicate that the decrease of NF-κB, and thus increase of IL-1Ra could be significant in tumor growth inhibition of CCR5−/− mice.
T9053 761-942 Sentence denotes The 3-methylcholatrene-induced tumor incidence was reduced in IL-1α knockout mice, but increased in IL-1Ra mice with concomitant maturation of NK cells and anti-tumor immunity [52].
T9052 627-760 Sentence denotes It is also noteworthy that IL-1Ra inhibited melanoma tumor growth by increasing the number of myeloid suppressor cells in tumor [25].
T9051 514-626 Sentence denotes These data indicate that NF-κB could be involved in the cytokine mediated anti-tumor activities of immune cells.
T9050 394-513 Sentence denotes In contrast, IL-23, a tumor growth promoting cytokine, increased NF-κB and immune cell infiltration in oral tumor [51].
T9049 228-393 Sentence denotes Thus, the decreased NF-κB and elevated IL-1Ra could also be associated in the infiltration of cytotoxic lymphocytes into tumor, resulting in tumor growth inhibition.
T9048 95-227 Sentence denotes Inhibition of NF-κB activity prevented NK cell depletion, and thus increased anti-tumor activity by decreasing IL-6 production [50].
T9047 0-94 Sentence denotes Activation of NF-κB could modulate subcellular localization of NK cells and pathogenesis [49].
T189 0-94 Sentence denotes Activation of NF-κB could modulate subcellular localization of NK cells and pathogenesis [49].
T190 95-227 Sentence denotes Inhibition of NF-κB activity prevented NK cell depletion, and thus increased anti-tumor activity by decreasing IL-6 production [50].
T191 228-393 Sentence denotes Thus, the decreased NF-κB and elevated IL-1Ra could also be associated in the infiltration of cytotoxic lymphocytes into tumor, resulting in tumor growth inhibition.
T192 394-513 Sentence denotes In contrast, IL-23, a tumor growth promoting cytokine, increased NF-κB and immune cell infiltration in oral tumor [51].
T193 514-626 Sentence denotes These data indicate that NF-κB could be involved in the cytokine mediated anti-tumor activities of immune cells.
T194 627-760 Sentence denotes It is also noteworthy that IL-1Ra inhibited melanoma tumor growth by increasing the number of myeloid suppressor cells in tumor [25].
T195 761-942 Sentence denotes The 3-methylcholatrene-induced tumor incidence was reduced in IL-1α knockout mice, but increased in IL-1Ra mice with concomitant maturation of NK cells and anti-tumor immunity [52].
T196 943-1083 Sentence denotes These data indicate that the decrease of NF-κB, and thus increase of IL-1Ra could be significant in tumor growth inhibition of CCR5−/− mice.

simple1

Id Subject Object Predicate Lexical cue
T9405 1070-1074 Protein denotes CCR5
T9404 1012-1018 Protein denotes IL-1Ra
T9403 861-867 Protein denotes IL-1Ra
T9402 823-828 Protein denotes IL-1α
T9401 654-660 Protein denotes IL-1Ra
T9400 267-273 Protein denotes IL-1Ra
T9399 206-210 Protein denotes IL-6

DLUT931

Id Subject Object Predicate Lexical cue
T11031 1056-1066 Negative_regulation denotes inhibition
T11030 1000-1008 Positive_regulation denotes increase
T11029 848-857 Positive_regulation denotes increased
T11028 829-837 Negative_regulation denotes knockout
T11027 288-298 Binding denotes associated
T11026 258-266 Positive_regulation denotes elevated
T11025 195-205 Negative_regulation denotes decreasing
T11024 211-221 Gene_expression denotes production
T10994 1070-1074 Protein denotes CCR5
T10993 1012-1018 Protein denotes IL-1Ra
T10992 861-867 Protein denotes IL-1Ra
T10991 823-828 Protein denotes IL-1α
T10990 654-660 Protein denotes IL-1Ra
T10989 267-273 Protein denotes IL-1Ra
T10988 206-210 Protein denotes IL-6
R7359 T11024 T11025 themeOf production,decreasing
R7362 T10988 T11024 themeOf IL-6,production
R7363 T10989 T11026 themeOf IL-1Ra,elevated
R7364 T10989 T11027 themeOf IL-1Ra,associated
R7365 T10991 T11028 themeOf IL-1α,knockout
R7366 T10992 T11029 themeOf IL-1Ra,increased
R7367 T10993 T11030 themeOf IL-1Ra,increase
R7368 T10994 T11031 themeOf CCR5,inhibition

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T11664 11-19 Protein denotes of NF-κB
T11663 823-828 Protein denotes IL-1α
T11660 1078-1082 Protein denotes mice
T11639 407-448 Protein denotes IL-23, a tumor growth promoting cytokine,
T11627 60-71 Entity denotes of NK cells
T11619 654-660 Protein denotes IL-1Ra
T11611 861-867 Protein denotes IL-1Ra
T11609 901-912 Entity denotes of NK cells
T11601 566-578 Protein denotes the cytokine
T11591 539-544 Protein denotes NF-κB
T11588 718-745 Entity denotes of myeloid suppressor cells
T11585 610-625 Entity denotes of immune cells
T11582 322-331 Entity denotes cytotoxic
T11580 823-843 Protein denotes IL-1α knockout mice,
T11579 109-114 Protein denotes NF-κB
T11559 319-343 Entity denotes of cytotoxic lymphocytes
T11549 206-210 Protein denotes IL-6
T11544 234-253 Protein denotes the decreased NF-κB
T11535 861-872 Protein denotes IL-1Ra mice
T11534 258-273 Protein denotes elevated IL-1Ra
T11533 981-989 Protein denotes of NF-κB
T11528 476-480 Entity denotes cell
T11518 134-141 Entity denotes NK cell
T11512 439-447 Protein denotes cytokine
T11510 1009-1018 Protein denotes of IL-1Ra
T11509 459-464 Protein denotes NF-κB
T11692 95-123 Negative_regulation denotes Inhibition of NF-κB activity
T11691 0-19 Positive_regulation denotes Activation of NF-κB
R7576 T11664 T11691 themeOf of NF-κB,Activation of NF-κB

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T12988 761-764 DT denotes The
T12987 759-760 . denotes .
T12986 758-759 NNP denotes ]
T12985 756-758 CD denotes 25
T12984 755-756 NNP denotes [
T12983 749-754 NN denotes tumor
T12982 746-748 IN denotes in
T12981 740-745 NNS denotes cells
T12980 729-739 NN denotes suppressor
T12979 721-728 JJ denotes myeloid
T12978 718-720 IN denotes of
T12977 711-717 NN denotes number
T12976 707-710 DT denotes the
T12975 696-706 VBG denotes increasing
T12974 693-695 IN denotes by
T12973 686-692 NN denotes growth
T12972 680-685 NN denotes tumor
T12971 671-679 NN denotes melanoma
T12970 661-670 VBN denotes inhibited
T12969 654-660 JJ denotes IL-1Ra
T12968 649-653 IN denotes that
T12967 638-648 JJ denotes noteworthy
T12966 633-637 RB denotes also
T12965 630-632 VBZ denotes is
T12964 627-629 PRP denotes It
T12963 625-626 . denotes .
T12962 620-625 NNS denotes cells
T12961 613-619 JJ denotes immune
T12960 610-612 IN denotes of
T12959 599-609 NNS denotes activities
T12958 588-598 JJ denotes anti-tumor
T12957 579-587 VBD denotes mediated
T12956 570-578 NN denotes cytokine
T12955 566-569 DT denotes the
T12954 563-565 IN denotes in
T12953 554-562 VBN denotes involved
T12952 551-553 VB denotes be
T12951 545-550 MD denotes could
T12950 539-544 NN denotes NF-κB
T12949 534-538 IN denotes that
T12948 525-533 VBP denotes indicate
T12947 520-524 NNS denotes data
T12946 514-519 DT denotes These
T12945 512-513 . denotes .
T12944 511-512 NNP denotes ]
T12943 509-511 CD denotes 51
T12942 508-509 NNP denotes [
T12941 502-507 NN denotes tumor
T12940 497-501 JJ denotes oral
T12939 494-496 IN denotes in
T12938 481-493 NN denotes infiltration
T12937 476-480 NN denotes cell
T12936 469-475 JJ denotes immune
T12935 465-468 CC denotes and
T12934 459-464 NNP denotes NF-κB
T12933 449-458 VBD denotes increased
T12932 447-448 , denotes ,
T12931 439-447 NN denotes cytokine
T12930 429-438 VBG denotes promoting
T12929 422-428 NN denotes growth
T12928 416-421 NN denotes tumor
T12927 414-415 DT denotes a
T12926 412-413 , denotes ,
T12925 407-412 NN denotes IL-23
T12924 405-406 , denotes ,
T12923 397-405 NN denotes contrast
T12922 394-396 IN denotes In
T12921 392-393 . denotes .
T12920 382-392 NN denotes inhibition
T12919 375-381 NN denotes growth
T12918 369-374 NN denotes tumor
T12917 366-368 IN denotes in
T12916 356-365 VBG denotes resulting
T12915 354-355 , denotes ,
T12914 349-354 NN denotes tumor
T12913 344-348 IN denotes into
T12912 332-343 NNS denotes lymphocytes
T12911 322-331 JJ denotes cytotoxic
T12910 319-321 IN denotes of
T12909 306-318 NN denotes infiltration
T12908 302-305 DT denotes the
T12907 299-301 IN denotes in
T12906 288-298 VBN denotes associated
T12905 285-287 VB denotes be
T12904 280-284 RB denotes also
T12903 274-279 MD denotes could
T12902 267-273 NN denotes IL-1Ra
T12901 258-266 VBD denotes elevated
T12900 254-257 CC denotes and
T12899 248-253 NN denotes NF-κB
T12898 238-247 VBN denotes decreased
T12897 234-237 DT denotes the
T12896 232-233 , denotes ,
T12895 228-232 RB denotes Thus
T12894 226-227 . denotes .
T12893 225-226 NNP denotes ]
T12892 223-225 CD denotes 50
T12891 222-223 NNP denotes [
T12890 211-221 NN denotes production
T12889 206-210 NN denotes IL-6
T12888 195-205 VBG denotes decreasing
T12887 192-194 IN denotes by
T12886 183-191 NN denotes activity
T12885 172-182 JJ denotes anti-tumor
T12884 162-171 VBD denotes increased
T12883 157-161 RB denotes thus
T12882 153-156 CC denotes and
T12881 151-152 , denotes ,
T12880 142-151 NN denotes depletion
T12879 137-141 NN denotes cell
T12878 134-136 NNP denotes NK
T12877 124-133 VBD denotes prevented
T12876 115-123 NN denotes activity
T12875 109-114 NNP denotes NF-κB
T12874 106-108 IN denotes of
T12873 95-105 NNP denotes Inhibition
T12872 93-94 . denotes .
T12871 92-93 NNP denotes ]
T12870 90-92 CD denotes 49
T12869 89-90 NNP denotes [
T12868 76-88 NN denotes pathogenesis
T12867 72-75 CC denotes and
T12866 66-71 NNS denotes cells
T12865 63-65 NNP denotes NK
T12864 60-62 IN denotes of
T12863 47-59 NN denotes localization
T12862 35-46 JJ denotes subcellular
T12861 26-34 VB denotes modulate
T12860 20-25 MD denotes could
T12859 14-19 NNP denotes NF-κB
T12858 11-13 IN denotes of
T12857 0-10 NNP denotes Activation
T13044 1082-1083 . denotes .
T13043 1078-1082 NNS denotes mice
T13042 1076-1077 NN denotes −
T13041 1075-1076 NN denotes /
T13040 1074-1075 CD denotes −
T13039 1070-1074 CD denotes CCR5
T13038 1067-1069 IN denotes of
T13037 1056-1066 NN denotes inhibition
T13036 1049-1055 NN denotes growth
T13035 1043-1048 NN denotes tumor
T13034 1040-1042 IN denotes in
T13033 1028-1039 JJ denotes significant
T13032 1025-1027 VB denotes be
T13031 1019-1024 MD denotes could
T13030 1012-1018 NN denotes IL-1Ra
T13029 1009-1011 IN denotes of
T13028 1000-1008 NN denotes increase
T13027 995-999 RB denotes thus
T13026 991-994 CC denotes and
T13025 989-990 , denotes ,
T13024 984-989 NNP denotes NF-κB
T13023 981-983 IN denotes of
T13022 972-980 NN denotes decrease
T13021 968-971 DT denotes the
T13020 963-967 IN denotes that
T13019 954-962 VBP denotes indicate
T13018 949-953 NNS denotes data
T13017 943-948 DT denotes These
T13016 941-942 . denotes .
T13015 940-941 NNP denotes ]
T13014 938-940 CD denotes 52
T13013 937-938 NNP denotes [
T13012 928-936 NN denotes immunity
T13011 917-927 JJ denotes anti-tumor
T13010 913-916 CC denotes and
T13009 907-912 NNS denotes cells
T13008 904-906 NNP denotes NK
T13007 901-903 IN denotes of
T13006 890-900 NN denotes maturation
T13005 878-889 JJ denotes concomitant
T13004 873-877 IN denotes with
T13003 868-872 NNS denotes mice
T13002 861-867 NN denotes IL-1Ra
T13001 858-860 IN denotes in
T13000 848-857 VBD denotes increased
T12999 844-847 CC denotes but
T12998 842-843 , denotes ,
T12997 838-842 NNS denotes mice
T12996 829-837 NN denotes knockout
T12995 823-828 JJ denotes IL-1α
T12994 820-822 IN denotes in
T12993 812-819 VBN denotes reduced
T12992 808-811 VBD denotes was
T12991 798-807 NN denotes incidence
T12990 792-797 NN denotes tumor
T12989 765-791 JJ denotes 3-methylcholatrene-induced
R8715 T12857 T12861 nsubj Activation,modulate
R8716 T12858 T12857 prep of,Activation
R8718 T12859 T12858 pobj NF-κB,of
R8719 T12860 T12861 aux could,modulate
R8720 T12861 T12861 ROOT modulate,modulate
R8722 T12862 T12863 amod subcellular,localization
R8723 T12863 T12861 dobj localization,modulate
R8724 T12864 T12863 prep of,localization
R8726 T12865 T12866 compound NK,cells
R8727 T12866 T12864 pobj cells,of
R8728 T12867 T12866 cc and,cells
R8730 T12868 T12869 compound pathogenesis,[
R8731 T12869 T12863 appos [,localization
R8732 T12870 T12871 nummod 49,]
R8734 T12871 T12869 appos ],[
R8735 T12872 T12861 punct .,modulate
R8736 T12873 T12877 nsubj Inhibition,prevented
R8738 T12874 T12873 prep of,Inhibition
R8739 T12875 T12876 compound NF-κB,activity
R8740 T12876 T12874 pobj activity,of
R8742 T12877 T12877 ROOT prevented,prevented
R8744 T12878 T12880 compound NK,depletion
R8745 T12879 T12880 compound cell,depletion
R8746 T12880 T12877 dobj depletion,prevented
R8748 T12881 T12877 punct ",",prevented
R8749 T12882 T12877 cc and,prevented
R8750 T12883 T12884 advmod thus,increased
R8752 T12884 T12877 conj increased,prevented
R8753 T12885 T12886 amod anti-tumor,activity
R8754 T12886 T12884 dobj activity,increased
R8756 T12887 T12884 prep by,increased
R8757 T12888 T12887 pcomp decreasing,by
R8759 T12889 T12890 compound IL-6,production
R8760 T12890 T12891 compound production,[
R8764 T12891 T12888 dobj [,decreasing
R8766 T12892 T12893 nummod 50,]
R8767 T12893 T12891 appos ],[
R8768 T12894 T12877 punct .,prevented
R8770 T12895 T12906 advmod Thus,associated
R8771 T12896 T12901 punct ",",elevated
R8773 T12897 T12899 det the,NF-κB
R8774 T12898 T12899 amod decreased,NF-κB
R8775 T12899 T12901 nsubj NF-κB,elevated
R8777 T12900 T12899 cc and,NF-κB
R8778 T12901 T12906 csubjpass elevated,associated
R8779 T12902 T12906 nsubjpass IL-1Ra,associated
R8781 T12903 T12906 aux could,associated
R8782 T12904 T12906 advmod also,associated
R8783 T12905 T12906 auxpass be,associated
R8785 T12906 T12906 ROOT associated,associated
R8786 T12907 T12906 prep in,associated
R8787 T12908 T12909 det the,infiltration
R8789 T12909 T12907 pobj infiltration,in
R8790 T12910 T12909 prep of,infiltration
R8791 T12911 T12912 amod cytotoxic,lymphocytes
R8792 T12912 T12910 pobj lymphocytes,of
R8793 T12913 T12909 prep into,infiltration
R8794 T12914 T12913 pobj tumor,into
R8796 T12915 T12906 punct ",",associated
R8797 T12916 T12906 advcl resulting,associated
R8798 T12917 T12916 prep in,resulting
R8799 T12918 T12919 compound tumor,growth
R8801 T12919 T12920 compound growth,inhibition
R8802 T12920 T12917 pobj inhibition,in
R8804 T12921 T12906 punct .,associated
R8805 T12922 T12933 prep In,increased
R8806 T12923 T12922 pobj contrast,In
R8808 T12924 T12933 punct ",",increased
R8809 T12925 T12933 nsubj IL-23,increased
R8810 T12926 T12925 punct ",",IL-23
R8812 T12927 T12929 det a,growth
R8813 T12928 T12929 compound tumor,growth
R8814 T12929 T12933 nsubj growth,increased
R8816 T12930 T12929 acl promoting,growth
R8817 T12931 T12930 dobj cytokine,promoting
R8818 T12932 T12929 punct ",",growth
R8820 T12933 T12933 ROOT increased,increased
R8821 T12934 T12933 dobj NF-κB,increased
R8823 T12935 T12934 cc and,NF-κB
R8824 T12936 T12938 amod immune,infiltration
R8825 T12937 T12938 compound cell,infiltration
R8827 T12938 T12934 conj infiltration,NF-κB
R8828 T12939 T12933 prep in,increased
R8829 T12940 T12941 amod oral,tumor
R8831 T12941 T12939 pobj tumor,in
R8832 T12942 T12944 nmod [,]
R8833 T12988 T12991 det The,incidence
R8834 T12943 T12944 nummod 51,]
R8835 T12944 T12933 npadvmod ],increased
R8836 T12945 T12933 punct .,increased
R8837 T12946 T12947 det These,data
R8838 T12947 T12948 nsubj data,indicate
R8839 T12948 T12948 ROOT indicate,indicate
R8840 T12989 T12991 amod 3-methylcholatrene-induced,incidence
R8841 T12949 T12953 mark that,involved
R8842 T12950 T12953 nsubjpass NF-κB,involved
R8843 T12951 T12953 aux could,involved
R8844 T12952 T12953 auxpass be,involved
R8845 T12953 T12948 ccomp involved,indicate
R8846 T12990 T12991 compound tumor,incidence
R8847 T12954 T12953 prep in,involved
R8848 T12955 T12956 det the,cytokine
R8849 T12956 T12954 pobj cytokine,in
R8850 T12991 T12993 nsubjpass incidence,reduced
R8851 T12992 T12993 auxpass was,reduced
R8852 T12957 T12953 conj mediated,involved
R8853 T12993 T12993 ROOT reduced,reduced
R8854 T12958 T12959 amod anti-tumor,activities
R8855 T12959 T12957 dobj activities,mediated
R8856 T12994 T12993 prep in,reduced
R8857 T12960 T12959 prep of,activities
R8858 T12961 T12962 amod immune,cells
R8859 T12962 T12960 pobj cells,of
R8860 T12995 T12997 amod IL-1α,mice
R8861 T12963 T12948 punct .,indicate
R8862 T12964 T12965 nsubj It,is
R8863 T12965 T12965 ROOT is,is
R8864 T12996 T12997 compound knockout,mice
R8865 T12966 T12965 advmod also,is
R8866 T12967 T12965 acomp noteworthy,is
R8867 T12997 T12994 pobj mice,in
R8868 T12968 T12973 nmod that,growth
R8869 T12969 T12973 amod IL-1Ra,growth
R8870 T12970 T12973 amod inhibited,growth
R8871 T12971 T12972 compound melanoma,tumor
R8872 T12998 T12993 punct ",",reduced
R8873 T12972 T12973 compound tumor,growth
R8874 T12973 T12965 attr growth,is
R8875 T12974 T12973 prep by,growth
R8876 T12999 T12993 cc but,reduced
R8877 T12975 T12974 pcomp increasing,by
R8878 T12976 T12977 det the,number
R8879 T12977 T12975 dobj number,increasing
R8880 T13000 T12993 conj increased,reduced
R8881 T12978 T12977 prep of,number
R8882 T12979 T12981 amod myeloid,cells
R8883 T12980 T12981 compound suppressor,cells
R8884 T13001 T13000 prep in,increased
R8885 T12981 T12978 pobj cells,of
R8886 T12982 T12977 prep in,number
R8887 T12983 T12982 pobj tumor,in
R8888 T13002 T13003 compound IL-1Ra,mice
R8889 T13003 T13001 pobj mice,in
R8890 T12984 T12986 nmod [,]
R8891 T12985 T12986 nummod 25,]
R8892 T12986 T12977 appos ],number
R8893 T12987 T12965 punct .,is
R8894 T13004 T13000 prep with,increased
R8895 T13005 T13006 amod concomitant,maturation
R8896 T13006 T13004 pobj maturation,with
R8899 T13007 T13006 prep of,maturation
R8903 T13008 T13009 compound NK,cells
R8906 T13009 T13007 pobj cells,of
R8910 T13010 T13009 cc and,cells
R8914 T13011 T13012 amod anti-tumor,immunity
R8917 T13012 T13006 conj immunity,maturation
R8921 T13013 T13015 nmod [,]
R8925 T13014 T13015 nummod 52,]
R8929 T13015 T13012 appos ],immunity
R8934 T13016 T12993 punct .,reduced
R8937 T13017 T13018 det These,data
R8938 T13018 T13019 nsubj data,indicate
R8940 T13019 T13019 ROOT indicate,indicate
R8941 T13020 T13032 mark that,be
R8942 T13021 T13022 det the,decrease
R8948 T13022 T13032 nsubj decrease,be
R8953 T13023 T13022 prep of,decrease
R8956 T13024 T13023 pobj NF-κB,of
R8959 T13025 T13022 punct ",",decrease
R8963 T13026 T13022 cc and,decrease
R8967 T13027 T13028 advmod thus,increase
R8971 T13028 T13022 conj increase,decrease
R8975 T13029 T13028 prep of,increase
R8979 T13030 T13029 pobj IL-1Ra,of
R8980 T13031 T13032 aux could,be
R8981 T13032 T13019 ccomp be,indicate
R8982 T13033 T13032 acomp significant,be
R8983 T13034 T13032 prep in,be
R8984 T13035 T13037 compound tumor,inhibition
R8985 T13036 T13037 compound growth,inhibition
R8986 T13037 T13034 pobj inhibition,in
R8987 T13038 T13037 prep of,inhibition
R8988 T13039 T13043 nummod CCR5,mice
R8989 T13040 T13043 nummod −,mice
R8990 T13041 T13043 nmod /,mice
R8991 T13042 T13043 compound −,mice
R8992 T13043 T13038 pobj mice,of
R8993 T13044 T13019 punct .,indicate

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T11340 1000-1008 Positive_regulation denotes increase
T11339 972-980 Negative_regulation denotes decrease
T11338 1070-1074 Protein denotes CCR5
T11337 1012-1018 Protein denotes IL-1Ra
T11336 984-989 Protein denotes NF-κB
T11335 654-660 Protein denotes IL-1Ra
T11334 539-544 Protein denotes NF-κB
T11333 449-458 Positive_regulation denotes increased
T11332 459-464 Protein denotes NF-κB
T11331 238-247 Negative_regulation denotes decreased
T11330 258-266 Positive_regulation denotes elevated
T11329 238-247 Negative_regulation denotes decreased
T11328 267-273 Protein denotes IL-1Ra
T11327 248-253 Protein denotes NF-κB
T11326 195-205 Negative_regulation denotes decreasing
T11325 211-221 Gene_expression denotes production
T11324 162-171 Positive_regulation denotes increased
T11323 95-105 Negative_regulation denotes Inhibition
T11322 206-210 Protein denotes IL-6
T11321 109-114 Protein denotes NF-κB
T11320 0-10 Positive_regulation denotes Activation
T11319 14-19 Protein denotes NF-κB
R7443 T11325 T11326 themeOf production,decreasing
R7445 T11328 T11329 themeOf IL-1Ra,decreased
R7447 T11328 T11330 themeOf IL-1Ra,elevated
R7448 T11330 T11331 themeOf elevated,decreased
R7451 T11332 T11333 themeOf NF-κB,increased
R7454 T11336 T11339 themeOf NF-κB,decrease
R7456 T11337 T11340 themeOf IL-1Ra,increase
R7498 T11319 T11320 themeOf NF-κB,Activation
R7500 T11321 T11323 themeOf NF-κB,Inhibition
R7502 T11322 T11325 themeOf IL-6,production
R7503 T11323 T11324 themeOf Inhibition,increased